D SEED THERAPEUTICS Trademark

Trademark Overview


On Wednesday, August 27, 2025, a trademark application was filed for D SEED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the D SEED THERAPEUTICS trademark a serial number of 99361665. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, January 21, 2026. This trademark is owned by SEED Therapeutics US, Inc.. The D SEED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protei...
d seed therapeutics

General Information


Serial Number99361665
Word MarkD SEED THERAPEUTICS
Filing DateWednesday, August 27, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, January 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesdrug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell
Description of MarkThe mark consists of the literal term SEED THERAPEUTICS with SEED in block letters and the second E backwards, and positioned above THERAPEUTICS, with a split hexagon positioned above the term SEED.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEED Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406
US

Trademark Events


Event DateEvent Description
Wednesday, August 27, 2025NEW APPLICATION ENTERED
Wednesday, August 27, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 16, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 16, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 20, 2026ASSIGNED TO EXAMINER
Wednesday, January 21, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 21, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 21, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED